Eckert & Ziegler Strahlen- und Medizintechnik AG confirmed earnings guidance for the year 2021. Based on the nine-month figures, the Executive Board continues to confirm the previously issued sales and earnings guidance of approximately EUR 180 million, or around EUR 1.70 per share.